Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
2.
Am J Emerg Med ; 54: 324.e5-324.e7, 2022 Apr.
Article in English | MEDLINE | ID: covidwho-1748330

ABSTRACT

Mycoplasma pneumoniae-induced rash and mucositis (MIRM) is a recently defined clinical entity characterized by pneumonia caused by M. pneumoniae with associated mucositis and frequent cutaneous lesions of a characteristic pattern. Although often similar in presentation, MIRM has distinct clinical and histologic features that are different from erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis. We report a case of MIRM in a nine-year-old boy.


Subject(s)
Erythema Multiforme , Exanthema , Mucositis , Pneumonia, Mycoplasma , Stevens-Johnson Syndrome , Child , Erythema Multiforme/diagnosis , Exanthema/etiology , Humans , Male , Mucositis/complications , Mycoplasma pneumoniae , Pneumonia, Mycoplasma/complications , Pneumonia, Mycoplasma/diagnosis , Stevens-Johnson Syndrome/etiology
3.
JAAD Case Rep ; 18: 103-105, 2021 Dec.
Article in English | MEDLINE | ID: covidwho-1540753
4.
Pediatr Int ; 63(8): 880-888, 2021 Aug.
Article in English | MEDLINE | ID: covidwho-949324

ABSTRACT

BACKGROUND: Kawasaki disease (KD) is an acute systemic vasculitis that predominantly affects patients younger than 5 years. In the absence of an available, affordable diagnostic test, detailed clinical history and physical examination are still fundamental to make a diagnosis. METHODS: We present five representative cases with KD-like presentations: systemic onset juvenile idiopathic arthritis, mycoplasma-induced rash and mucositis, staphylococcal scalded skin syndrome, BCGosis, and the recently described multisystemic inflammatory syndrome in children (MIS-C) associated with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) virus. RESULTS: Rash, fever, and laboratory markers of inflammation can be present in several childhood diseases that may mimic KD. CONCLUSION: The term 'Kawasaki syndrome' instead of 'Kawasaki disease' may be more appropriate. Physicians should consider an alternative diagnosis that may mimic KD, particularly considering MIS-C during the present pandemic, as an aggressive diagnostic and therapeutic approach is needed.


Subject(s)
COVID-19 , Mucocutaneous Lymph Node Syndrome , Child , Humans , Mucocutaneous Lymph Node Syndrome/diagnosis , RNA, Viral , SARS-CoV-2 , Systemic Inflammatory Response Syndrome
SELECTION OF CITATIONS
SEARCH DETAIL